自動免疫測定分析装置の世界市場：2023-2030年

自動免疫測定分析装置の世界市場は、予測期間中（2023-2030年）にCAGR 14.8％で成長すると予測されています。自動免疫測定分析装置は、特定の血液サンプル中に存在するタンパク質分析物の検出を支援する免疫測定試験に使用される医療機器の一種です。同装置の使用は、公開検査における利点と操作の正確さにより増加しています。微生物ベースの感染症を診断・検出するための免疫測定に対する需要の増加は、免疫測定分析装置市場の成長と需要を促進すると予想される重要な要因の一つです。

セグメント別展望

感染症サブセグメントが自動免疫測定分析装置の世界市場でかなりのシェアを占めると予測される

用途別では、感染症サブセグメントが自動免疫測定分析装置の世界市場で大きなシェアを占めると予測されています。このセグメントの成長の背景には、感染症の流行の増加が、自動免疫測定分析装置市場の成長を促進する重要な要因の1つとなっていることが挙げられます。感染症の早期発見は、身体への深刻なダメージの可能性を減らすために重要です。そのため、肝炎、インフルエンザ、性病、その他多数の感染症などを最小限の時間で適切かつ正確にスクリーニングすることが、市場の主要な成長要因になると予測されています。それゆえ、企業はより良いスクリーニングのための新しく先進的な自動ソリューションの導入に注力しています。例えば、2023年7月、Beckman Coulter Diagnostics社は、自動化学分析装置である新しいDxC 500 AU Chemistry AnalyzerのFDA認可を取得し、同社の臨床化学製品を拡大し、体外診断業界における製品革新への継続的なコミットメントを示しました。中小規模の検査室向けに設計されたDxC 500 AU Chemistry Analyzerは、検査室のワークフローを最適化し、重要な臨床判断をサポートするために設計されたベックマン・コールターの最新ソリューションの一つです。

地域別展望

世界の自動免疫測定分析装置市場は、北米（米国、カナダ）、欧州（英国、イタリア、スペイン、ドイツ、フランス、その他欧州地域）、アジア太平洋地域（インド、中国、日本、韓国、その他アジア地域）、世界のその他の地域（中東とアフリカ、中南米）を含む地域別にさらに細分化されています。なかでもアジア太平洋地域は、急速な技術開拓と様々な用途での免疫測定検査利用の増加により、世界全体で大きなシェアを占めると予想されています。例えば、2023年4月に中国のFapon Biotech Inc.が革新的な化学発光ワンストップ・ソリューション戦略を発表しました。Fapon chemiluminescence one-stop solutionは化学発光製品とサービスの完全な範囲を提供するように設計されており、オープンシステムプラットフォームを備えた様々なレベルの全自動化学発光分析装置、試薬開発サポート、バルク生産の高品質コア原材料で構成されています。Fapon Biotechは、現地の体外診断（IVD）パートナーが迅速に製品ポートフォリオを拡大し、生産プロセスを合理化し、化学発光イムノアッセイ業界でのビジネスを加速できるよう支援することを目指しています。

北米地域は世界の自動免疫測定分析装置市場で大きなCAGRで成長する見込み

すべての地域の中で、北米地域は予測期間中にかなりのCAGRで成長すると予測されています。この地域の成長は、老人人口の増加とライフスタイルの急速な変化に起因しています。また、医療製品の入手が容易で、先進技術やヘルスケアにおける自動化製品の採用率が高いことも背景にあります。例えば、2023年1月、Qiagen社は、診断ラボにおける自動サンプリング用のEZ2 Connect MDx IVDプラットフォームを発表しました。同社は、このプラットフォームを調査用に提供してから18ヵ月後に、広く使用できるようにします。EZ2 Connect MDx装置は高度に自動化されており、検査室は最大24検体からDNAとRNAの並行精製を30分で行うことができます。このプラットフォームは、カナダ、米国、その他の国々で入手可能であり、欧州連合（EU）およびこの呼称を受け入れている他の国々のための体外診断用医薬品（IVD）のEU CE-IVD適合マークを持っています。

従って、自動免疫測定分析装置製造の採用に向けた国のかなりのシフトがあります。医療機器の動向の変化と進歩は、この地域の市場収益の成長を支え続けると予想される他の主要な要因です。例えば、2023年7月、Beckman Coulter社は北米で初めてDxI 9000 Access Immunoassay Analyzerを発表し、スピード、信頼性、再現性、品質、メニュー拡張に対する臨床検査室の要求に対応しました。DxI 9000アナライザーは、より高感度で臨床的に適切なアッセイを開発する能力を備えており、ヘルスケアプロバイダーや製薬会社がこれまで以上に困難な課題を抱える疾病に挑む中、このプラットフォームは明日の検査要件に対応することができます。

目次

第1章 レポート概要

• 業界の現状分析と成長可能性の展望
• 調査方法とツール
• 市場内訳
  • セグメント別
  • 地域別

第2章 市場概要と洞察

• 調査範囲
• アナリストの洞察と現在の市場動向
  • 主な調査結果
  • 推奨事項
  • 結論

第3章 競合情勢

• 主要企業分析
• Abbott Laboratories
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• Carolina Liquid Chemistries Corp
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• F. Hoffmann-La Roche AG
  • 概要
  • 財務分析
  • SWOT分析
  • 最近の動向
• 主要戦略分析

第4章 市場セグメンテーション

• 世界の自動免疫測定分析装置市場：用途別
  • 感染症
  • 内分泌学
  • 薬物モニタリング
  • 慢性疾患
  • アレルギー検査
• 世界の自動免疫測定分析装置市場：製品別
  • 免疫蛍光
  • 化学発光
  • 酵素連動蛍光システム
  • ラジオイムノアッセイ

第5章 地域別分析

• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • イタリア
  • スペイン
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋
• 世界のその他の地域

第6章 企業プロファイル

• Aesku Diagnotics
• Arlington Scientific
• Becton Dickinson and Company
• Biokit S.A
• BioMerieux
• BioRad Laboratories
• Inova DX
• Luminex Corporation
• Meril Life Sciences
• Ortho Clinical Diagnostics
• Perkin Elmer
• Randox Laboratories
• Siemens Healthcare

LIST OF TABLES

• 1. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 2. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR INFECTIOUS DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 3. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR ENDOCRINOLOGY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 4. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR DRUG MONITORING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 5. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR CHRONIC DISEASES MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 6. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR ALLERGY TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 7. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
• 8. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN IMMUNOFLUORESCENCE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 9. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN CHEMILUMINESCENCE MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 10. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN ENZYME LINKED FLUORESCENT SYSTEM MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 11. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 12. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
• 13. NORTH AMERICAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 14. NORTH AMERICAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 15. NORTH AMERICAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
• 16. EUROPEAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 17. EUROPEAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 18. EUROPEAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
• 19. ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 20. ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 21. ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)
• 22. REST OF THE WORLD AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
• 23. REST OF THE WORLD AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
• 24. REST OF THE WORLD AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022-2030 ($ MILLION)

LIST OF FIGURES

• 1. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
• 2. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR INFECTIOUS DISEASES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 3. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR ENDOCRINOLOGY MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 4. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR DRUG MONITORING MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 5. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR CHRONIC DISEASES MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 6. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER FOR ALLERGY TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 7. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2022 VS 2030 (%)
• 8. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN IMMUNOFLUORESCENCE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 9. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN CHEMILUMINESCENCE MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 10. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN ENZYME LINKED FLUORESCENT SYSTEM MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 11. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER IN RADIOIMMUNOASSAY MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 12. GLOBAL AUTOMATIC IMMUNOASSAY ANALYZER MARKET SHARE BY REGION, 2022 VS 2030 (%)
• 13. US AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
• 14. CANADA AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
• 15. UK AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
• 16. FRANCE AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
• 17. GERMANY AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
• 18. ITALY AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
• 19. SPAIN AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
• 20. REST OF EUROPE AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
• 21. INDIA AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
• 22. CHINA AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
• 23. JAPAN AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
• 24. SOUTH KOREA AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
• 25. REST OF ASIA-PACIFIC AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)
• 26. REST OF THE WORLD AUTOMATIC IMMUNOASSAY ANALYZER MARKET SIZE, 2022-2030 ($ MILLION)

Title: Global Automatic Immunoassay Analyzer Market Size, Share & Trends Analysis Report by Application (Infectious Diseases, Endocrinology, Drug Monitoring, Chronic Diseases, and Allergy Testing), and by Product (Immunofluorescence, Chemiluminescence, Enzyme Linked Fluorescent System, and Radioimmunoassay)Forecast Period (2023-2030).

The global Automatic Immunoassay Analyzer market is anticipated to grow at a CAGR of 14.8% during the forecast period (2023-2030). Automatic Immunoassay analyzers are the type of medical devices that are used for the immunoassay test which helps in the detection of protein analyze present in a specific blood sample. Their usage is growing owing to their benefits in publishing tests and the accurateness of their operations. The rise in demand for immunoassay to diagnose and detect microorganism-based infections is amongst the significant factors expected to fuel the growth and demand of immunoassay analyzers market.

Segmental Outlook

The global Automatic Immunoassay Analyzer market is segmented on the Application and product. Based on the application, the market is sub-segmented into infectious diseases, endocrinology, drug monitoring, chronic diseases, and allergy testing. based on the product, the market is sub-segmented into immunofluorescence, chemiluminescence, enzyme linked fluorescent system, and radioimmunoassay. Among the application, the Chronic Diseases sub-segment is anticipated to hold a considerable share of the market, owing to the increasing prevalence of chronic diseases such as diabetes, cardiovascular diseases, cancer, and infectious diseases has driven the demand for diagnostic tools like immunoassay analyzers.

The Infectious diseases Sub-Segment is Anticipated to Hold a Considerable Share of the Global Automatic Immunoassay Analyzer Market

Among the application, the infectious diseases sub-segment is expected to hold a considerable share of the global automatic immunoassay analyzer market. The segmental growth is attributed to Increasing prevalence of infectious diseases is one of the crucial factors that is conventional to drive automated immunoassay analyzers market growth. Early detection of infectious diseases is important to reduce the possibility of severe damage to the body. Thus, proper and accurate screening of infections such as Hepatitis, influenza, STDs, and numerous other infections in minimal time is projected to be a major market growth factor. Hence companies are focusing on introducing new and advanced automatic solution for better screening. For an instance, in July 2023, Beckman Coulter Diagnostics, received FDA clearance for its new DxC 500 AU Chemistry Analyzer, an automated chemistry analyzer, expanding the company's clinical chemistry offering and demonstrating ongoing commitment to product innovation in the in vitro diagnostic industry. Designed for small-to-medium-sized laboratories, the DxC 500 AU Chemistry Analyzer is one of several recent Beckman Coulter solutions designed to optimize laboratory workflows and support critical clinical decisions.

Regional Outlook

The global automatic immunoassay analyzer market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing the rapid technological developments and increase in usage of immunoassay testing for various applications. For instance, in April 2023, Chinese firm Fapon Biotech Inc. announced its innovative chemiluminescence one-stop solution strategy. Fapon chemiluminescence one-stop solution is designed to provide a complete range of chemiluminescence products and services, consisting of different levels of fully automatic chemiluminescence analysers with open system platforms, reagent development support, as well as high quality core raw material in bulk production. Fapon Biotech aims to help local in-vitro diagnostic (IVD) partners quickly extend their product portfolio and streamline their production processes, as well as accelerate their business in the chemiluminescence immunoassay industry.

The North America Region is Expected to Grow at a Significant CAGR in the Global Automatic Immunoassay Analyzer Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the rising in Geriatric Population and Rapid Change in Lifestyle. Correspondingly owing to easy availability of medical products along with advanced technologies and the high adoption rate of the automatic products in healthcare. For an instance, in January 2023, Qiagen has launched the EZ2 Connect MDx IVD platform for automated sampling in diagnostic laboratories. The company is offering the platform for widescale use 18 months after it was made available for research. The EZ2 Connect MDx device has a high degree of automation and enables laboratories to perform parallel purification of DNA and RNA from up to 24 samples in 30 minutes. Available in Canada, the US and other countries, the platform has EU CE-IVD compliance marking for in-vitro devices (IVD) for the European Union and other countries accepting this designation.

Hence, there is considerable shift of the country towards the adoption of the Automatic Immunoassay Analyzer production. Owing to changing trends and advancements in Medical Devices are other key factors expected to continue to support market revenue growth in the region. For an instance, in July 2023, Beckman Coulter, revealed for the first time in North America the DxI 9000 Access Immunoassay Analyzer, addressing clinical laboratory demands for speed, reliability, reproducibility, quality, and menu expansion. The DxI 9000 Analyzer has shown capability to develop increasingly sensitive and clinically relevant assays enabling the platform to keep pace with tomorrow's testing requirements as healthcare providers and pharmaceutical companies take aim at evermore challenging diseases.

Market Players Outlook

The major companies serving the global automatic immunoassay analyzer market include F. Hoffmann-La Roche Ltd., Abbott, BD, Beckman Coulter, Inc., Ortho Clinical Diagnostics, bioMerieux SA, Biokit S.A, The Binding Site Group Ltd., Quidel Corporation, Immunodiagnostic Systems, Merck KGaA, Olympus Corporation, Nova Century Scientific, Inc., Luminex Corporation, DiaSorin S.p.A., Bio-Rad Laboratories, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in February 2023, Agilent Technologies Inc. announced their xCELLigence RTCA HT (real-time cell analysis high-throughput) platform which integrates with the BioTek BioSpa 8 Automated Incubator. Developed in response to market needs, this combination enables a higher level of workflow automation that provides novel functionality for the development of label-free high-throughput potency assays for the immuno-oncology space and high-throughput viral cytopathic effects (CPE) assays for the vaccine market.

The Report Covers:

• Market value data analysis of 2022 and forecast to 2030.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global automatic immunoassay analyzer market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Region

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
• 3.2. Abbott Laboratories
  • 3.2.1. Overview
  • 3.2.2. Financial Analysis
  • 3.2.3. SWOT Analysis
  • 3.2.4. Recent Developments
• 3.3. Carolina Liquid Chemistries Corp
  • 3.3.1. Overview
  • 3.3.2. Financial Analysis
  • 3.3.3. SWOT Analysis
  • 3.3.4. Recent Developments
• 3.4. F. Hoffmann-La Roche AG
  • 3.4.1. Overview
  • 3.4.2. Financial Analysis
  • 3.4.3. SWOT Analysis
  • 3.4.4. Recent Developments
• 3.5. Key Strategy Analysis

4. Market Segmentation

• 4.1. Global Automatic Immunoassay Analyzer Market by Application
  • 4.1.1. Infectious Diseases
  • 4.1.2. Endocrinology
  • 4.1.3. Drug Monitoring
  • 4.1.4. Chronic Diseases
  • 4.1.5. Allergy Testing
• 4.2. Global Automatic Immunoassay Analyzer Market by Product
  • 4.2.1. Immunofluorescence
  • 4.2.2. Chemiluminescence
  • 4.2.3. Enzyme Linked Fluorescent System
  • 4.2.4. Radioimmunoassay

5. Regional Analysis

• 5.1. North America
  • 5.1.1. United States
  • 5.1.2. Canada
• 5.2. Europe
  • 5.2.1. UK
  • 5.2.2. Germany
  • 5.2.3. Italy
  • 5.2.4. Spain
  • 5.2.5. France
  • 5.2.6. Rest of Europe
• 5.3. Asia-Pacific
  • 5.3.1. China
  • 5.3.2. India
  • 5.3.3. Japan
  • 5.3.4. South Korea
  • 5.3.5. Rest of Asia-Pacific
• 5.4. Rest of the World

6. Company Profiles

• 6.1. Aesku Diagnotics
• 6.2. Arlington Scientific
• 6.3. Becton Dickinson and Company
• 6.4. Biokit S.A
• 6.5. BioMerieux
• 6.6. BioRad Laboratories
• 6.7. Inova DX
• 6.8. Luminex Corporation
• 6.9. Meril Life Sciences
• 6.10. Ortho Clinical Diagnostics
• 6.11. Perkin Elmer
• 6.12. Randox Laboratories
• 6.13. Siemens Healthcare